![Anne Doering](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anne Doering
Keine laufenden Positionen mehr
Vermögen: - $ am 31.10.2026
Profil
Ms. Anne M.
Doering was previously employed as a Portfolio Manager & Research Analyst by Franklin Templeton Investment Management Ltd. (Germany), a Director-Investor Relations by BioNTech SE, an Investment Manager by Creathor Venture Management GmbH, a Director-Group Strategy by Merck KGaA, and a Chief Financial Officer & Executive Director by Vivoryon Therapeutics NV.
She received her graduate degree from the University of Pennsylvania, a graduate degree from Joseph H Lauder Institute of Management & International and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.03.2025 | 0 ( -.--% ) | - $ | 31.10.2026 |
Ehemalige bekannte Positionen von Anne Doering
| Unternehmen | Position | Ende |
|---|---|---|
Franklin Templeton Investment Management Ltd. (Germany)
 Franklin Templeton Investment Management Ltd. (Germany) Investment ManagersFinance FTIML-Germany is a value-oriented manager which specializes in European fixed-income and equity, investing across all major asset classes, including equities, fixed-income, real estate and alternative investments. The firm's analysts perform in-house research and follow a bottom-up approach to identify stocks they believe are underpriced relative to their future potential. | Analyst-Equity | 01.01.2019 |
Creathor Venture Management GmbH
 Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture invests in companies located primarily in Germany, France and Switzerland as well as in the rest of Europe. The firm focuses on technology and health care sectors. It provides financing for seed and early stage capital requirements with an investment size of EUR 0.05 - 2.5 million. The firm acts as lead investor and also acquires minority stakes. | Private Equity Investor | 01.11.2010 |
| MERCK KGAA | Corporate Officer/Principal | - |
| BIONTECH SE | Investor Relations Kontakt | - |
| VIVORYON THERAPEUTICS N.V. | Finanzdirektor/CFO | - |
Ausbildung von Anne Doering
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Creathor Venture Management GmbH
Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture invests in companies located primarily in Germany, France and Switzerland as well as in the rest of Europe. The firm focuses on technology and health care sectors. It provides financing for seed and early stage capital requirements with an investment size of EUR 0.05 - 2.5 million. The firm acts as lead investor and also acquires minority stakes. | Finance |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
Franklin Templeton Investment Management Ltd. (Germany)
Franklin Templeton Investment Management Ltd. (Germany) Investment ManagersFinance FTIML-Germany is a value-oriented manager which specializes in European fixed-income and equity, investing across all major asset classes, including equities, fixed-income, real estate and alternative investments. The firm's analysts perform in-house research and follow a bottom-up approach to identify stocks they believe are underpriced relative to their future potential. | Finance |
Joseph H Lauder Institute of Management & International
 Joseph H Lauder Institute of Management & International Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
